Drug intelligence / Profile preview

1-[1-(3-aminophenyl)-3-tert-butyl-1H-pyrazol-5-yl]-3-phenylurea

Development stage
Unknown
Modality
Small Molecules
01

Overview

This compound is a synthetic small molecule belonging to the phenylpyrazole class, with the molecular formula C20H23N5O and a molecular weight of approximately 349.4 g/mol. It is an experimental agent that has not been approved for any therapeutic use. The primary known mechanism of action is inhibition of the proto-oncogene tyrosine-protein kinase Src (SRC), a non-receptor tyrosine kinase involved in cellular signaling pathways related to proliferation, differentiation, and survival. There are no reported clinical indications or approvals for this compound, and it appears to be used primarily as a research tool in biochemical studies targeting SRC[2][3][4].

Other names
1-(1-(3-Aminophenyl)-3-tert-butyl-1H-pyrazol-5-yl)-3-phenylurea3-(1-(3-Aminophenyl)-3-tert-butyl-1H-pyrazol-5-yl)-1-phenylurea3-[1-(3-Aminophenyl)-3-tert-butyl-1H-pyrazol-5-y]-1-phenyulrea
02

Targets

SRC (Proto-oncogene tyrosine-protein kinase Src)

Beyond the preview

Go deeper on 1-[1-(3-aminophenyl)-3-tert-butyl-1H-pyrazol-5-yl]-3-phenylurea.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 1-[1-(3-aminophenyl)-3-tert-butyl-1H-pyrazol-5-yl]-3-phenylurea.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call